Review on sulphonamide analogues for the perspective of antibacterial and antidiabetic activity
Department of Pharmaceutical Chemistry, Amity Institute of Pharmacy, Amity University, Gwalior, Madhya Pradesh, India.
Review Article
GSC Advanced Research and Reviews, 2024, 19(02), 178–189.
Article DOI: 10.30574/gscarr.2024.19.2.0022
Publication history:
Received on 15 December 2023; revised on 04 March 2024; accepted on 07 March 2024
Abstract:
Several facets of sulphonamides are covered in this overview, including their chemistry, history, structure-activity relationship, classification systems, and contemporary synthesis techniques. The review also covers the range of sulphonamides pharmacological effects as antibacterial and antidiabetic agents. Sulphonamides work by competitively limiting microorganisms' ability to produce vitamin Bc, which stops bacteria from proliferating but does not actually kill them and need to be used against a range of fungi and gram-positive and gram-negative bacteria. According to the International Diabetes Federation's global cartographic image of diabetes (http://www.diabetesatlas.org/), type 2 diabetes mellitus (T2DM) is a pandemic that affects people worldwide. Hyperglycemia is the primary symptom of diabetes mellitus, a chronic, progressive, and poorly understood metabolic disease and discussed the mechanisms of metformin, glitazones, sulphonyl urea’s and other agents. Worldwide, copious research has been conducted on molecular targets associated with type 2 diabetes, including PPAR-γ, incretin, GLP-1, DPP-4, and SGLT2, DPP-IV, GSK-3, Aldose-reductase, fructose-bisphosphatases, and β3 adrenoceptor are used to treat type 2 diabetes.
Keywords:
Sulphonamide; Antibacterial; Antidiabetic; Biochemical Target; Synthetic scheme
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
